Conference Coverage
Conference Coverage
‘Praise Diabetes’: Support programs in Black churches yield lasting A1c changes
Statistically significant reductions in A1c and diabetes distress were seen in the Praise Diabetes Project, a 33-month randomized trial, an...
Conference Coverage
Anti-VEGF injections for diabetic retinopathy linked to mortality risk
Results suggest a need to be “very careful” with treatment choice in certain patients, investigator says, though much more research is needed to...
Conference Coverage
AMPLITUDE-O: Efpeglenatide benefits in high-risk diabetes
In older patients with long-time type 2 diabetes and CVD or kidney disease, the investigational GLP-1 agonist efpeglenatide was safe and lowered...
Conference Coverage
Semaglutide 2.4 mg ‘likely to usher in a new era’ in obesity treatment
Clinical experience with this drug will grow rapidly over the next few years, one expert predicts, and new combination drugs are near, so...
Conference Coverage
'Full throttle': 'Diabetes Garage' workshops boost Mexican American men's self-management
Infusing diabetes education with concepts and lingo from car culture is a promising approach to improving self-management behaviors, and might...
Conference Coverage
Nocturnal hypoglycemia halved with insulin degludec vs. glargine
Researchers pitted degludec against glargine U100 in the toughest patients with type 1 diabetes, those who had severe nocturnal hypoglycemia.
Conference Coverage
Omnipod 5 ‘artificial pancreas’ shows benefit in type 1 diabetes
If approved by the FDA, it would be the third commercially available semiautomated insulin delivery system in the United States and the first...
Conference Coverage
Intervention opens access to care for minority youths with type 1 diabetes
Program adds support for children with diabetes and their families who are struggling because of lack of resources or marginalization in the...
Conference Coverage
Type 1 diabetes amputation rates fall in Sweden, rise in U.S.
Coupled with renal and A1c data, the findings suggest improved prognosis for these patients, Swedish investigators say.
Conference Coverage
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight loss
For patients with type 2 diabetes, doubling the weekly semaglutide dose modestly improved glycemic control and weight loss while maintaining...